WST Deadline: WST Investors Have Opportunity to West Pharmaceutical Services, Inc. Securities Fraud Lawsuit
NEW YORK, June 20, 2025 /PRNewswire/ —
Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of West Pharmaceutical Services, Inc. (NYSE: WST) between February 16, 2023 and February 12, 2025, both dates inclusive (the 'Class Period'), of the important July 7, 2025 lead plaintiff deadline.
So what: If you purchased West Pharmaceutical common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
What to do next: To join the West Pharmaceutical class action, go to https://rosenlegal.com/submit-form/?case_id=39367 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email case@rosenlegal.com for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than July 7, 2025. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.
Why Rosen Law: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm achieved the largest ever securities class action settlement against a Chinese Company at the time. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers.
Details of the case: According to the lawsuit, throughout the Class Period, defendants made false and misleading statements and/or failed to disclose that: (1) despite claiming strong visibility into customer demand and attributing headwinds to temporary COVID-related product destocking, West was in fact experiencing significant and ongoing destocking across its high-margin High-Value Products ('HVP') portfolio; (2) West's SmartDose device, which was purportedly positioned as a high-margin growth product, was highly dilutive to West's profit margins due to operational inefficiencies; (3) these margin pressures created the risk of costly restructuring activities, including West's exit from continuous glucose monitoring ('CGM') contracts with long-standing customers; and (4) as a result of the foregoing, defendants' positive statements about West's business, operations, and prospects were materially false and/or misleading or lacked a reasonable basis. When the true details entered the market, the lawsuit claims that investors suffered damages.
To join the West Pharmaceutical class action, go to https://rosenlegal.com/submit-form/?case_id=39367, https://rosenlegal.com/submit-form/?case_id=28116call Phillip Kim, Esq. toll-free at 866-767-3653 or email case@rosenlegal.com for information on the class action.
No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.
Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.
Attorney Advertising. Prior results do not guarantee a similar outcome.
Contact Information:
Laurence Rosen, Esq. Phillip Kim, Esq. The Rosen Law Firm, P.A. 275 Madison Avenue, 40th Floor New York, NY 10016 Tel: (212) 686-1060 Toll Free: (866) 767-3653 Fax: (212) 202-3827 case@rosenlegal.com www.rosenlegal.com
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Star
2 hours ago
- The Star
Manufacturing sector raises ‘triple blow' concerns
PETALING JAYA: A textile and apparel trade group has urged the government to engage with industry stakeholders to re-evaluate the tax scope of the expanded Sales and Service Tax (SST), which starts today. Malaysian Knitting Manufacturers Association president Wayne Lian said this is to ensure the policy is sustainable and flexible. He explained that the expanded SST will create a 'triple blow' to Malaysian businesses. Lian said the detrimental effects would be due to rising costs, higher tax burdens and inflation. He noted that the global geopolitical tensions have pushed up raw material and logistics costs, significantly compressing profit margins. 'However, beyond global instability, Malaysian businesses are also grappling with a series of domestic policy and cost burdens,' Lian said in a statement yesterday. He added that the manufacturing sector is facing multiple challenges through several policies that could affect their financial stability. 'In recent months, manufacturers have faced multiple challenges, including the increase in minimum wage, diesel subsidy rationalisation, higher electricity and natural gas tariffs, implementation of the e-invoicing system, mandatory 2% EPF contributions for foreign workers, fluctuations in currency exchange rates, and rising raw material prices. 'These cumulative factors have substantially driven up operating expenses, placing unprecedented strain on businesses, particularly small and medium enterprises,' he said. Lian also said that the tariffs imposed by the United States on a wide range of imported goods have disrupted the global trade flows and indirectly affected Malaysian businesses. 'At the same time, Malaysia is facing a surge in low-priced imports from China, as Chinese manufacturers, faced with overcapacity and global trade restrictions, are dumping products into regional markets. 'This practice is undercutting domestic industries and placing further pressure on local producers already struggling with tight margins,' he added.
The Star
3 hours ago
- The Star
China fund beats 97% of peers by buying Pop Mart
A statue of the character Labubu at the Pop Land theme park, operated by Pop Mart International Group Ltd., in Beijing, China, on Friday, June 27, 2025. Labubu, Beijing toymaker Pop Mart's star character, is fueling a global collectibles craze. Photographer: Na Bian/Bloomberg BEIJING: A 30-year-old Chinese fund manager is trouncing peers this year with a portfolio stocked with Gen Z-favoured names like Pop Mart International Group, betting that new-age shopping trends can help his fund overcome the country's economic sluggishness. Xie Tianyuan's Penghua Selected Return Flexible Allocation Mixed Fund has returned 24% this year, ranking in the top 3% among roughly 2,300 peers, data from fund tracker East Money Information Co show. That's a turnaround from its recent past when holdings in traditional sectors like alcoholic beverages and farming dragged performance. The Shenzhen-based fund manager, who took over in early 2024, wasted little time in replacing what was then the fund's top holding, Kweichow Moutai Co, a baijiu distiller, with the maker of smash-hit Labubu dolls, Pop Mart. His repositioning for the fund, which has about US$7mil in assets under management, reflects how cultural shifts – brought on by digital influence and youth spending – are creating opportunities for Chinese investors navigating broader challenges in the world's second-largest economy. His conviction strengthened after witnessing the popularity of the toymaker's products in Thailand, which, he says, signalled 'non-linear growth with every metric showing breakout potential'. Growing up immersed in Japanese anime culture – his desk is adorned with Dragon Ball Z figurines – Xie said he developed an eye for identifying promising characters or designs, called 'IP brands' by mixing personal fandom and online research. That he himself is demographically a member of Gen Z, the driving force behind China's new 'emotional spending' consumption trend, helps him understand what may resonate beyond advertising and go viral. 'Opportunities in the sector in the years to come will be on the single-stock level as the population dividend comes to an end,' he said. 'I pick companies that have breakthrough products, new business models and innovative sales channels – products that are both visually appealing and fun.' His top pick, Pop Mart, accounted for 10.5% of the fund's total assets as of March, the top end of its maximum ownership in a single stock allowed, filings show. Other big bets include Mao Geping Cosmetics Co, up 83% this year, as well as Chongqing Baiya Sanitary Products Co and Yantai China Pet Foods Co. Xie's strategy lies firmly in targeting the Gen Z consumption trend, where purchase decisions are driven by emotional triggers and hobby interests. Despite looming threats from Donald Trump's proposed tariff hikes, this behavioural change fuelled rallies in pockets of China's stock market, especially after the momentum from artificial intelligence began to fade. Shares of the companies at the heart of this trend – including Pop Mart and Laopu Gold Co, known for distinctive gold pendants – have staged wild gains this year. Laopu is up more than 2,000% since its initial public offering in Hong Kong a year ago. Xie's fund owns shares that trade in the mainland as well as in Hong Kong. A gauge for Chinese stocks listed in Hong Kong has risen 20% this year. The mainland's benchmark, the CSI 300, had edged down 0.3% so far this year. The rally has expanded to include sectors like medical aesthetics, pet foods and even vape products. — Bloomberg
The Star
4 hours ago
- The Star
Factory activity decline eases after trade truce
Tariff ceasefire: Workers at a plastics factory in Shenzhen. For all the attention on Trump's pledge to bring mass manufacturing back to American shores, China's factories are finding ways to remain central to the global supply chain. — Bloomberg BEIJING: China's factory activity improved for a second month but remained in contraction, as trade rebounded after the ceasefire in the tariff war with the United States, while weak domestic demand weighed on the economy. The official manufacturing purchasing managers' index (PMI) was 49.7 in June, versus 49.5 in the previous month, slightly exceeding the median estimate in a Bloomberg survey of analysts. A reading below 50 indicates contraction. The non-manufacturing measure of activity in construction and services rose to 50.5 from 50.3 last month, the National Bureau of Statistics (NBS) said yesterday. That compared with a forecast of 50.3. The offshore yuan extended its gain after the data release and was 0.2% stronger at 7.1626 per US dollar. Futures on 30-year government bonds fell as much as 0.6%, the most in a month, as traders dialled back bets on further monetary easing. For manufacturing, the new orders index expanded for the first time in three months, though a gauge of employment worsened again after a slight improvement in May. Among the 21 industries surveyed, more than half were in expansion territory, according to the statistics service. 'Manufacturing production activities accelerated and market demand improved,' Zhao Qinghe, a senior NBS statistician, said in a statement. The PMI figures are the first official data available each month to provide a snapshot of the Chinese economy. The latest reading captured the first full month after Beijing and Washington agreed to a 90-day truce in their trade war. Overseas demand, which made up almost 40% of economic growth in the first quarter, is helping compensate for sluggish spending by consumers at home. But it also makes China more reliant on maintaining stable ties with trade partners such as the United States, with whom Beijing just finalised a trade framework negotiated in Geneva. The pact codified the terms laid out in trade talks between the United States and China, including a commitment from Beijing to deliver rare earths used in everything from wind turbines to jet planes. The strength of Chinese manufacturing in the rest of the year remains in question given an uncertain export outlook, with a more lasting trade deal still elusive. Several global banks, including Bank of America Corp and Citigroup Inc, recently raised forecasts for China's growth in 2025 as the tariff truce improves confidence. Even so, economists surveyed by Bloomberg expect gross domestic product to expand 4.5% this year, significantly below the official target of around 5%. With the manufacturing output index hitting a three-month high of 51, industrial production in June 'won't be too bad', said Raymond Yeung, chief economist for Greater China at Australia and New Zealand Banking Group Ltd. 'The question for policymakers is deflation and joblessness instead of growth,' he said. 'I am not worried about China's gross domestic product.' President Donald Trump's China envoy, David Perdue, recently warned the United States wanted to revamp its trading relationship with China and the world by bringing many critical supply chains back onshore. The US ambassador said American leaders had been 'blind to the hollowing out of many US strategic industries', a sign that trade tensions between the two nations could persist. — Bloomberg
